Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

4 Key Points To Look For In Gilead Sciences Earnings Report

Gilead Sciences (NASDAQ:GILD) is one of the most intriguing companies due to its revolutionary Hepatitis C (HCV) treatments. Unlike most conventional remedies that offer chronic treatment, (a virtual annuity like revenue stream) GILD treatments actually provide a "cure" thus obliterating the traditional monthly revenue we are accustomed to seeing. To say the least, the unconventional treatment regimen has caused wide issues with trying to build accurate models for GILD as the opinions from analysts are all over the board. The article below will highlight the four key areas I will focus on from the upcoming earnings…